Sustained activation of renal N-methyl-D-aspartate receptors decreases vitamin D synthesis: a possible role for glutamate on the onset of secondary HPT

Simple item page
dc.contributor.authorParisi Capdevila, Eva
dc.contributor.authorBozić Stanojević, Milica
dc.contributor.authorIbarz Escuer, Mercedes
dc.contributor.authorPanizo García, Sara
dc.contributor.authorValcheva, Petya
dc.contributor.authorColl, Blai
dc.contributor.authorFernández i Giráldez, Elvira
dc.contributor.authorValdivielso Revilla, José Manuel
dc.date.accessioned2016-06-09T08:29:39Z
dc.date.embargoEndDate2025-01-01
dc.date.issued2010
dc.description.abstractN-methyl-D-aspartate (NMDA) receptors (NMDAR) are tetrameric amino acid receptors that act as membrane calcium channels. The presence of the receptor has been detected in the principal organs responsible for calcium homeostasis (kidney, bone, and parathyroid gland), pointing to a possible role in mineral metabolism. The aim of this study was to test the effect of NMDAR activation in the kidney and on 1,25(OH)2D3 synthesis. We determined the presence of NMDAR subunits in HK-2 (human kidney cells) cells and proved its functionality. NMDA treatment for 4 days induced a decrease in 1 -hydroxylase levels and 1,25(OH)2D3 synthesis through the activation of the MAPK/ERK pathway in HK-2 cells. In vivo administration of NMDA for 4 days also caused a decrease in blood 1,25(OH)2D3 levels in healthy animals and an increase in blood PTH levels. This increase in PTH induced a decrease in the urinary excretion of calcium and an increase in urinary excretion of phosphorous and sodium as well as in diuresis. Bone turnover markers also increased. Animals with 5/6 nephrectomy showed low levels of renal 1 -hydroxylase as well as high levels of renal glutamate compared with healthy animals. In conclusion, NMDAR activation in the kidney causes a decrease in 1,25(OH)2D3 synthesis, which induces an increase on PTH synthesis and release. In animals with chronic kidney disease, high renal levels of glutamate could be involved in the downregulation of 1 -hydroxylase expression.ca_ES
dc.description.sponsorshipThis work was supported by FIS PI09/0299, FIS PI07/0427, and REDINREN (16/06).ca_ES
dc.identifier.doihttps://doi.org/10.1152/ajpendo.00428.2010
dc.identifier.idgrec017129
dc.identifier.issn0193-1849
dc.identifier.urihttp://hdl.handle.net/10459.1/57176
dc.language.isoengca_ES
dc.publisherAmerican Physiological Societyca_ES
dc.relation.isformatofReproducció del document publicat a https://doi.org/10.1152/ajpendo.00428.2010ca_ES
dc.relation.ispartofAJP- Endocrinology and Metabolism, 2010, vol. 299, núm. 5, p. E825-E831ca_ES
dc.rights(c) American Physiological Society, 2010ca_ES
dc.rights.accessRightsinfo:eu-repo/semantics/restrictedAccessca_ES
dc.subjectParatyroid hormoneca_ES
dc.subjectMitogen- activated protein kinaseca_ES
dc.subjectHyerparatyroidismca_ES
dc.titleSustained activation of renal N-methyl-D-aspartate receptors decreases vitamin D synthesis: a possible role for glutamate on the onset of secondary HPTca_ES
dc.typearticleca_ES
dc.type.versionpublishedVersionca_ES
Files
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Articles publicats (Medicina i Cirurgia)